2 recruiting, 1 not yet recruiting. 2 Phase 2, 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow CART Infusion: new trials by email Literature Review of CART Infusion trials Research Report on CART Infusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas CART Infusion - Lymphoma Nonhodgkin, Marginal Zone B Cell Lymphoma | Phase 2 | Not yet recruiting | Kure Cells, INC | 105 | 2026-08-31 | 2026-07-20 |
| Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas CART infusion - B-cell Lymphoma Refractory | Phase 1 / Phase 2 | Recruiting | National University Hospital, Singapore | 30 | 2026-03-02 | 2026-04-09 |
| UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases CART Infusion - Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenic Purpura | Early Phase 1 | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 27 | 2026-02-03 | 2026-03-02 |
Anemia, Hemolytic, Autoimmune (1) · Evans Syndrome (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1)
Kure Cells, INC (1) · National University Hospital, Singapore (1) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (1)
China (1) · Singapore (1)
Michelle Poon (1)
PMID 20660832, PMID 24876563, PMID 26755709, PMID 28925994, PMID 29155426, PMID 29419431, PMID 29437609, PMID 30501490, PMID 30518502, PMID 30592986, PMID 31056762, PMID 31723828, PMID 32278358, PMID 33147337, PMID 33512414, PMID 34041526, PMID 34312556, PMID 34642489